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Human cytomegalovirus (HCMV) causes a broad spectrum of clinical manifestations in immunocompromised patients,
including infection of the gastrointestinal tract. To investigate the role of epithelial cells in the gastrointestinal HCMV disease,
we used the intestinal epithelial cell line Caco-2, which is permissive for HCMV replication. In differentiated Caco-2 cells, we
showed previously that HCMV infection proceeds preferentially from the basolateral membrane, suggesting that receptors
for HCMV may be contained predominantly in the basolateral membrane (A. Esclatine et al., 2000, J. Virol. 74, 513–517).
Therefore, we examined expression and localization in Caco-2 cells of heparan sulfate (HS) proteoglycan and annexin II,
previously implicated in initial events of HCMV infection. We observed that annexin II is expressed in Caco-2 cells, but is not
essential for entry of HCMV. We showed that, during the differentiation process, HS, initially present on the entire surface
of the membrane of undifferentiated cells, ultimately became sequestered at the basolateral cell surface of fully differenti-
ated cells. We established by biochemical assays that membrane-associated HS proteoglycan mediates both viral attach-
ment to, and subsequent infection of, Caco-2 cells, regardless of the cell differentiation state. Thus, the redistribution of HS
is implicated in the basolateral entry of HCMV into differentiated Caco-2 cells. © 2001 Academic Press
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Human cytomegalovirus (HCMV), a member of the
herpesvirus family, causes severe diseases in immuno-
compromised individuals, notably infection of the gastro-
intestinal system. The mechanism of the HCMV infection
of the gastrointestinal tract is still poorly understood. For
studying interactions between microorganisms and the
intestine, one of the most efficient enterocyte-like models
is represented by the Caco-2 cell line. Caco-2 cells are
human intestinal epithelial cells that spontaneously un-
dergo processes of polarization and differentiation in
culture, mimicking the physiological differentiation pro-
cess along the crypt-to-villus axis (Pinto et al., 1983;
Zweibaum et al., 1991). The transition process from un-
differentiated to differentiated Caco-2 cells is a pivotal
change in cell organization by establishment of polariza-
tion, which delineates two clearly distinguishable
plasma membrane domains (Louvard et al., 1992). Orga-
nization of these polarized domains occurs through the
control of the junctional complex, which is a highly de-
veloped structure that functions as a “fence” separating
1 To whom correspondence and reprint requests should be ad-
ressed at INSERM U-510, Faculte´ de Pharmacie, 5 rue J. B. Cle´ment,
2296 Chaˆtenay-Malabry Cedex, France. Fax: 33-1 46 83 58 44. E-mail:
udrey.esclatine@cep.u-psud.fr.
23apical and basolateral domains, thereby segregating cell
surface proteins and lipids into each domain (Denker
and Nigam, 1998). We previously reported that HCMV
strain AD169 can infect and replicate in Caco-2 cells
independently of the differentiation state of the cells
(Esclatine et al., 2000). However, we and others have
demonstrated that entry of HCMV is restricted to the
basolateral surface of polarized Caco-2 cells (Esclatine
et al., 2000; Jarvis et al., 1999). It is generally believed that
the asymmetric distribution of viral receptors on the sur-
faces of epithelial cells is responsible for the polarity of
infection exhibited by some viruses (for review see Com-
pans, 1995; Tucker and Compans, 1993). Therefore, ba-
solateral entry of HCMV in Caco-2 cells could reflect the
polarized distribution of receptors on the basolateral
surface of differentiated cells.
The entry of HCMV into cells is a complex process
requiring sequential interaction between multiple cellu-
lar and viral components. In fibroblasts, HCMV initiates
infection via attachment to cell surface heparan sulfate
(HS) proteoglycans (Compton et al., 1993; Neyts et al.,
1992). Cell surface HS are exploited as attachment mol-
ecules by many other viruses, including herpes simplex
virus types 1 and 2 (WuDunn and Spear, 1989), HIV (Patel
et al., 1993), dengue virus (Chen et al., 1997; Hilgard and
Stockert, 2000), vaccinia virus (Chung et al., 1998), and
adenoassociated virus (Duan et al., 1998). Interestingly,
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24 ESCLATINE ET AL.because of its initial interaction with HS, recombinant
adenoassociated virus was found to transduce essen-
tially the basolateral surface of lung epithelial cells
(Duan et al., 1998). Interaction between HCMV and HS
proteoglycans is critical for HCMV entry and allows sec-
ondary binding to high-affinity receptors (Compton,
1995). Several cell surface molecules have been pro-
posed as high-affinity receptors not only in fibroblasts,
but also in endothelial cells. These include annexin II, a
cellular nonidentified 92.5-kDa protein, and the human
aminopeptidase N (Keay and Baldwin, 1991; Soderberg
et al., 1993; Wright et al., 1994). Annexin II, a calcium-
ependent phospholipid-binding protein (Moss, 1997),
as been shown to bind specifically to HCMV virions and
o contribute to HCMV attachment to vascular endothe-
ial cells (Wright et al., 1994). However, the role of an-
exin II is controversial since Pietropaolo and Compton
1999) have recently demonstrated that annexin II is not
equired for HCMV entry into fibroblasts and proposed
hat the role of annexin II in HCMV infection is dependent
n the cell type. Most of the knowledge of HCMV entry
athway is based on studies done on cultured fibroblast
ell lines. However, HCMV is capable of infecting several
ifferent cell types and the virus may have multiple
echanisms of entry into cells as a function of cell types
Bodaghi et al., 1999).
The purpose of the present study was to investigate
the cellular distribution of HS and annexin II during
Caco-2 cell differentiation and the implication of these
molecules in the restricted entry of HCMV into differen-
tiated Caco-2 cells. Indeed, proteoglycans are generally
localized at the basolateral domain of polarized epithelial
cells because they function as matrix receptors on the
basal surface of these cells (Day et al., 1999; Tanabe et
al., 1999) and annexin II is concentrated in the basolat-
eral membrane domain of polarized enterocytes (Mas-
sey-Harroche et al., 1998).
RESULTS
Heparan sulfate is expressed on the entire surface of
undifferentiated and on the basolateral surface of
differentiated Caco-2 cells
We studied the subcellular distribution of HS on
Caco-2 cells during differentiation by confocal micros-
copy. Monolayers of undifferentiated (5-day-old) and fully
differentiated (14-day-old) cells were fixed and incubated
with an FITC-labeled anti-HS antibody. We observed
membrane staining on the entire surface of undifferenti-
ated cells (Figs. 1A and 1B). HS was also detected on the
membrane of fully differentiated cells (Fig. 1C). However,
as shown in an x–z plane section, HS immunoreactivityecame mainly localized to the basolateral surface of
ifferentiated cells (Fig. 1D).ell surface HS is required for HCMV infection of
aco-2 cells regardless of the differentiation state
We investigated the involvement of HS in infection of
ndifferentiated and fully differentiated Caco-2 cells with
CMV. The ability of heparin (a highly sulfated version of
S), chondroitin sulfate, or dextran sulfate (an artificial
ighly sulfated polymer) to competitively inhibit infection
f Caco-2 cells with HCMV was analyzed by expression
f HCMV immediate-early (IE) proteins 48 h postinfection
y flow cytometry (Fig. 2). Increasing concentrations of
AGs were added to the viral inoculum immediately prior
o infection of Caco-2 cells. Data obtained are summa-
ized in Fig. 2D and show that heparin inhibits virus
nfection of undifferentiated Caco-2 cells in a dose-de-
endent manner (IC50 3.23 mg/ml). Inhibition by heparin
reached almost 90% at 50 mg/ml. Chondroitin sulfate and
dextran sulfate did not show any significant inhibition at
concentrations of up to 50 mg/ml. Fully differentiated
cells grown on filter were infected basolaterally in the
presence of increasing concentrations of GAGs. Hepa-
rin, but not chondroitin sulfate or dextran sulfate, also
inhibited virus infection of fully differentiated Caco-2
cells in a dose-dependent manner (data not shown).
We next examined the effect of enzymatic cleavage of
cell surface proteoglycans on HCMV infectivity. Caco-2
cells were cultured in the presence of either heparinase
I or III or chondroitinase and monitored for IE antigens
expression. Heparinase I degrades heparin and highly
sulfated domains in HS. Heparinase III is specific for HS,
and chondroitinase cleaves chondroitin sulfate. Figure
3A shows that heparinase I blocked about 70% of the
infectivity in undifferentiated cells and heparinase III
inhibits almost 50%, while chondroitinase had minimal, if
any, protective effect. We observed a more significant
inhibition by heparinase treatment in fully differentiated
Caco-2 cells infected basolaterally (Fig. 3B). Heparinase
III blocked 96% of the infectivity and heparinase I inhib-
ited 83%.
HCMV binds to cell surface heparan sulfate
To further understand in which part of the viral life
cycle HS might play a role, we analyzed the effect of
soluble GAGs and degrading enzymes on the binding of
35S-labeled virus to undifferentiated Caco-2 cells. For
hese experiments, Caco-2 cells were seeded at 2 3 105
per milliliter and used 2 days after seeding, just reaching
confluence. 35S-labeled virus preparations were preincu-
ated with soluble GAGs at various concentrations and
dded to cells. After incubation with cells, the mixture
as removed and cells were washed and solubilized to
uantify bound 35S virus. Heparin inhibited up to 66% of
HCMV binding in a concentration-dependent manner
(Fig. 4A). Again, chondroitin sulfate and dextran sulfate
had no effect on virus binding to cells.
Treatment of Caco-2 cells with heparinase I and III
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25LOCALIZATION OF HS LIMITS HCMV ENTRY IN Caco-2 CELLScaused a significant decrease in the binding of radiola-
beled HCMV to the cell surface, while chondroitinase
had minimal effect (Fig. 4B). Taken together, these re-
sults indicate that HCMV initiates infection via attach-
ment to cell surface HS proteoglycans.
Expression and subcellular distribution of annexin II
and annexin II light chain in Caco-2 cells
Annexin II exists either as a monomer or as an het-
erotetramer complexed to the annexin II light chain (or
p11) (Waisman, 1995). We determined expression of an-
nexin II and its light chain in Caco-2 cells by Western blot
analysis of soluble cell and membrane extracts. We used
undifferentiated and fully differentiated Caco-2 cells. As
shown in Fig. 5, we observed specific bands correspond-
ing to 38 kDa for annexin II and to 11 kDa for p11 in
membrane cell extracts of undifferentiated and fully dif-
FIG. 1. Localization of HS in undifferentiated Caco-2 cells (A and B)
monoclonal antibody against HS as described under Materials and Me
an FITC-labeled secondary antibody followed by counterstaining of
evaluated by confocal microscopy in horizontal sections (A and C). Th
represents the same plane at a higher magnification.ferentiated cells. Thus, annexin II and p11 are expressed
in Caco-2 cells independent of the state of differentiation.
C
sSubcellular distribution of annexin II and p11 was
determined in fully differentiated Caco-2 cells by immu-
nofluorescent staining using polyclonal anti-annexin II
antibody and monoclonal antibody (MAb) anti-p11. Coun-
terstaining was performed with propidium iodide. In fully
differentiated Caco-2 cells, annexin II and p11 membrane
staining was observed throughout the monolayer when
cells were permeabilized (Figs. 6A and 6D). An x–z plane
ection (Figs. 6B and 6E) reveals the presence of an-
exin II in apical and basolateral membranes, whereas
11 localizes only to the apical membrane. However,
hen the cells were nonpermeabilized (Figs. 6C and 6F),
part of the cells did not express annexin II and the
ther cells expressed a different staining pattern than
ermeabilized cells. This staining appeared as patches
estricted to a part of the cell membrane.
The staining pattern observed in undifferentiated
fully differentiated Caco-2 cells (C and D). Cells were incubated with
Immunoreactivity was detected by indirect immunofluorescence using
with propidium iodide (in red). Immunostaining of monolayers were
fields were analyzed in vertical sections (x--z) (B and D). Insert in Dand in
thods.
nuclei
e sameaco-2 cells was similar (data not shown). Membrane
taining with annexin II and p11 antibodies was detected
ts with
in sulfa
26 ESCLATINE ET AL.in all permeabilized cells. In nonpermeabilized cells,
annexin II and p11 immunoreactivity was localized in
patches on some cells.
In conclusion, annexin II and p11 were mainly local-
ized on the inner face of the cell membrane and were
therefore intracellular in both undifferentiated and fully
differentiated Caco-2 cells.
Annexin II is not required for Caco-2 cell infection
with HCMV
It was reported that in several ligand-blot analyses
performed as a virus overlay assay, HCMV particles bind
FIG. 2. Soluble heparin blocks HCMV infection of Caco-2 cells. Ce
concentrations for 45 min at 37°C. Cells were then washed with PBS
expression by flow cytometry. (A–C) Representative fluorescence flow
Infected Caco-2 cells with (B) 50 mg/ml heparin, (C) 50 mg/ml chondroit
the percentage of fluorescence-positive cells of one of three experimen
obtained by flow cytometry with different GAGs (heparin l, chondroit
FIG. 3. Heparinase I and III block HCMV infection of Caco-2 cells. C
heparinase III (M) or chondroitinase ABC () at different concentrations (U/m
differentiated (B) Caco-2 cells.to two membrane proteins of 32 and 34 kDa (Adlish et al.,
1990). Both groups proposed that annexin II represents
at least one of these proteins (Compton, 1995; Wright et
al., 1994). Using a similar virus overlay assay, we ob-
served that radiolabeled HCMV preparation bound to
two bands with approximate molecular masses of 32 and
34 kDa in Caco-2 cell lysates (Fig. 7). However, Western
blot assay of the same cell lysate was performed with
anti-annexin II polyclonal antibody in the same experi-
ment, under the same experimental conditions (not
boiled, not denatured). This assay showed a unique
band of 38 kDa, indicating that, at least in Caco-2 cells,
re infected with HCMV in the presence of different GAGs at various
ixed 48 h postinfection. Infected cells were evaluated for IE antigen
etric histograms of undifferentiated cells stained for IE proteins. (A)
te. The gray histogram represents noninfected cells. Numbers indicate
similar results. The bar represents the proportion of positive cells. Data
te M, and dextran sulfate ) are summarized in D.
re pretreated with proteoglycan degrading enzymes, heparinase I (l),lls we
and f
cytom
in sulfaells we
l) for 1 h and then infected with HCMV. Undifferentiated (A) and fully
ase AB
a bound
C
P
d
(
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27LOCALIZATION OF HS LIMITS HCMV ENTRY IN Caco-2 CELLSthe two HCMV binding proteins were different from an-
nexin II (Fig. 7, lane 3).
To investigate the role of annexin II in initial interac-
tions of HCMV with Caco-2 cells, we tested whether
anti-annexin II polyclonal antibody could block HCMV
entry into Caco-2 cells. The inhibitory effect of antibodies
was measured by expression of HCMV IE proteins 24 h
postinfection by indirect immunofluorescence. As shown
in Fig. 8, treatment of undifferentiated (A) or fully differ-
entiated (B) Caco-2 cells with different dilutions of anti-
annexin II polyclonal antibody had no effect on infectivity.
Consistent with these results, we showed that some of
the cells, which expressed viral antigens and were there-
fore infected, do not express extracellular membrane-
bound annexin II (Fig. 9).
Taken together, these results indicate that the local-
ization of annexin II does not correlate with the restric-
tion of HCMV to basolateral entry in Caco-2 cells.
FIG. 4. Effect of different GAGs and enzymatic digestion on HCMV b
presence of heparin l, chondroitin sulfate M, or dextran sulfate  at the
degrading enzymes heparinase I (l), heparinase III (M), or chondroitin
verage percentage inhibition relative to the counts per minute (cpm)
FIG. 5. Expression of annexin II and annexin II light chain (p11) in
aco-2 cells. Membrane cell extracts were separated by 10% SDS–
AGE and transferred to nitrocellulose membrane, and proteins were
etected by antibodies against annexin II (lanes 1 and 2) and p11lanes 3 and 4). Fully differentiated Caco-2 cells (lanes 1 and 3).
ndifferentiated Caco-2 cells (lanes 2 and 4).DISCUSSION
In a previous work, we demonstrated that both undif-
ferentiated and fully differentiated Caco-2 cells are per-
missive for HCMV replication and that HCMV enters
predominantly through the basolateral surface of differ-
entiated Caco-2 cells (Esclatine et al., 2000). Polar entry
of virus into polarized epithelial cells generally reflects
the distribution of their receptors on a specific mem-
brane domain (Blau and Compans, 1996; Tucker and
Compans, 1993). In fibroblast cells, entry of HCMV re-
quires an initial attachment to HS followed by an inter-
action with a second “high-affinity” protein receptor
(Compton, 1995). In this study, we investigated if local-
ization in Caco-2 cells of HS and annexin II, previously
reported to be involved in initial events of HCMV infec-
tion, could explain the restricted entry of HCMV into
differentiated Caco-2 cells. Our data implicated HS in the
attachment of HCMV to Caco-2 cells, regardless of the
differentiation state. Moreover, localization of HS on
Caco-2 cells during the differentiation process revealed
that HS, initially present on the entire surface of the
membrane of undifferentiated cells, ultimately becomes
sequestered at the basolateral cell surface of fully differ-
entiated cells. Therefore, HS cellular distribution corre-
lates exactly with the entry pattern of HCMV into Caco-2
cells, leading to the basolateral entry of HCMV into
differentiated Caco-2 cells.
Such redistribution of cell surface proteoglycans has
been reported by Rapraeger et al. (1986) in mouse mam-
mary epithelial cells. Proteoglycans surround cells
grown in subconfluent or newly confluent monolayers,
but when the cells differentiate, proteoglycans are lost
from the apical cell surface and localize almost solely at
the basolateral surface. In differentiated Caco-2 cells,
Mertens et al. (1996) identified three major cell surface
HS proteoglycans expressed as syndecan 1 and 4 and
glypican. They showed by domain-specific biotinylation
(A) 35S-labeled virus was added to undifferentiated Caco-2 cells in the
ted concentrations. (B) Caco-2 cells were pretreated with proteoglycan
C () before addition of 35S-labeled virus. Data are represented as the
in the absence of treatment.inding.
indicaexperiments that these HS proteoglycans are mainly
concentrated in the basolateral membrane compartment.
anning
d cells.
28 ESCLATINE ET AL.We investigated the role of HS in HCMV entry into
Caco-2 cells. We have shown that binding and infection
of Caco-2 cells by HCMV is sensitive to competitive
FIG. 6. Localization of annexin II (A, B, and C) and annexin II light ch
with anti-annexin II, or anti-p11 antibodies detected with FITC-labele
Horizontal sections (A and D) were generated by confocal laser sc
permeabilized cells. (C and F) Horizontal sections of nonpermeabilize
FIG. 7. Binding of HCMV particles to Caco-2 cell proteins. Caco-2 cell
proteins were separated by 10% SDS–PAGE under minimally denatur-
ing conditions (not boiled and not reduced), transferred to nitrocellu-
lose membrane filters, and probed with 35S-labeled HCMV particles:
lane 1, overlay of HCMV on blot of total cell lysates; lane 2, overlay of
HCMV on blot of membrane extracts; lane 3, immunostaining of an-
nexin II in same conditions. Representative assay of three independent
experiments is shown.inhibition with heparin, a soluble HS analog, but not with
chondroitin sulfate. Dextran sulfate, an artificial highly
sulfated polysaccharide, has no effect on HCMV infec-
tion in this cell type. This provides compelling evidence
that the inhibitory effect observed with heparin is not
simply a nonspecific charge effect, but rather indicates a
specific receptor-like interaction. Removal of HS from the
1) (D, E, and F) in fully differentiated Caco-2 cells. Cells were labeled
ndary antibodies, and counterstained with propidium iodide (in red).
microscopy of permeabilized cells. (B and E) x–z plan section of
FIG. 8. Entry of HCMV into cells pretreated with anti-annexin II
antibody. Undifferentiated (A) and fully differentiated (B) Caco-2 cells
were pretreated with various dilutions of anti-annexin II polyclonal
serum for 60 min at 37°C prior and during HCMV adsorption. Infected
cells were evaluated by IE antigens expression. Each value representsain (p1
d secothe average of triplicate samples and error bars indicate the standard
deviation between values.
antibo
s pres
29LOCALIZATION OF HS LIMITS HCMV ENTRY IN Caco-2 CELLSsurface of the Caco-2 cells by the specific HS-degrading
enzymes, heparinase I and III, reduced virus attachment
and infection, as measured by cell surface virus attach-
ment and IE antigen expression. Results were similar in
both undifferentiated and fully differentiated Caco-2
cells. Compton et al. (1993) previously reported initial
interaction of HCMV with HS proteoglycan in fibroblasts
and in CHO cells, but this is the first report of a role for
HS proteoglycan in HCMV attachment in epithelial intes-
tinal cells.
Annexin II was proposed by Wright et al. (1994) as an
HCMV receptor in endothelial cells and is preferentially
expressed in the basolateral domain of polarized rabbit
enterocytes (Massey-Harroche et al., 1998). However,
expression and localization of annexin II in the epithelial
intestinal Caco-2 cell line has, to our knowledge, never
been studied. Our work demonstrated by Western blot
analysis that annexin II and its light chain p11 are ex-
pressed by Caco-2 cells regardless of the state of differ-
entiation. Analysis of annexin II and p11 subcellular dis-
tribution in these cells showed that, although these pro-
teins are associated with membranes, they seem to be
mainly intracellular. Moreover, extracellular membrane-
bound annexin II appears mainly localized in the apical
domain of differentiated cells (data not shown), which
does not support the hypothesis of a role for this protein
in enabling basolateral entry of HCMV into Caco-2 cells.
Annexin II might nevertheless be a receptor for HCMV in
Caco-2 cells but failure of specific polyclonal antibody
directed against annexin II to inhibit infection indicates a
lack of involvement of annexin II in HCMV entry per se
into Caco-2 cells. We also showed that cells that do not
express extracellular membrane-bound annexin II can
be infected by HCMV. Finally, Adlish et al. (1990) and
FIG. 9. Undifferentiated cells were infected with HCMV, fixed 24 h pos
was detected with FITC-labeled secondary antibody. The cells were th
HCMV IE proteins, which was detected with TRITC-labeled secondary
bound annexin II. B shows only annexin II staining in the same cells aothers (Nowlin et al., 1991; Taylor and Cooper, 1990)
showed previously that HCMV binds predominantly tofibroblastic membrane proteins of 30–34 kDa. Several
authors hence proposed that annexin II, known to have a
molecular mass of 34 kDa, represents at least one of
these proteins and that the lower molecular weight
bands could be proteolytic fragments (Compton, 1995;
Wright et al., 1994). In our study using ligand-blot analy-
sis, we showed that HCMV binds specifically to two
membrane proteins of 32 and 34 kDa of Caco-2 cells, but
that neither of the two binding proteins is annexin II.
Indeed, we observed that under that same experimental
approach and conditions, annexin II migrated as a band
of 38 kDa instead of 32 or 34 kDa. In fact, identity
between annexin II and the 32–34 kDa proteins has
never been proved and the identity of these proteins
remains unknown. Taken together our results reveal that
annexin II is not implicated in viral entry into Caco-2
cells. Similarly, we demonstrated that p11 is not neces-
sary for HCMV entry into Caco-2 cells (data not shown).
Our results agree with those of Pietropaolo et al. (1999),
who found that annexin II and p11 are not essential for
entry of HCMV into fibroblast cells. However, astrocy-
toma cells transfected with the major HCMV envelope
glycoprotein gB is able to fuse to neighboring cells and
fusion was inhibited by a MAb against annexin II (Bold et
al., 1996). It was proposed that the role of annexin II in
HCMV entry, as well as the entry mechanism itself,
varies from one type of cell to another (Pietropaolo and
Compton, 1999).
Requirements for virus binding and entry may differ
between cell types, notably for viruses which have a
broad cellular tropism (Schneider-Schaulies, 2000). Re-
cently, the involvement of HS in cellular infection by HIV-1
was reexamined and shown to be facilitated by HS in
only one of three highly permissive cell lines and not in
ion, and immunostained with anti-annexin II polyclonal antibody, which
meabilized with Triton X-100 and incubated with antibody E13 against
dy. Numerous infected cells do not express extracellular membrane-
ented in A.tinfect
en perprimary lymphocytes (Ibrahim et al., 1999). CD21 has
been identified as a receptor for the g-herpesvirus Ep-
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30 ESCLATINE ET AL.stein Barr virus (EBV) in B cells (Nemerow et al., 1986).
However, gastric carcinoma cells which do not express
CD21 are susceptible to EBV infection and infection is
mediated via a receptor other than CD21 (Yoshiyama et
al., 1997). Our results parallel these findings in that an-
nexin II is not involved in HCMV entry, though it may be
involved in endothelial infection (Wright et al., 1994).
HCMV enters into fibroblasts by pH-independent fusion
between the virus envelope and the host-cell plasma
membrane (Compton et al., 1992). However, Bodaghi et
al. (1999) recently demonstrated that HCMV penetrates
endothelial and retinal epithelial cells by endocytosis,
showing that mode of viral entry differs between cell
types. These data suggest that different molecules may
be implicated in HCMV entry into endothelial and epi-
thelial cells compared to those involved for fibroblasts.
Interestingly, polarity of HCMV entry differs also between
cell types since entry of HCMV is restricted to apical
membrane in the human retinal epithelial cells (Tugizov
et al., 1996).
In summary, our findings show that initial HCMV bind-
ing to HS proteoglycans restricts entry of HCMV to the
basolateral membrane domain in polarized Caco-2 cells.
However, definitive evidence that HS proteoglycans are
sufficient for this restriction will require further investiga-
tion. After initial attachment to HS, HCMV probably inter-
acts with a second high-affinity receptor(s) (not annexin
II), whose identity is now under investigation.
MATERIALS AND METHODS
Virus
The AD169 strain of HCMV was used throughout this
study. Virus was maintained in human embryonic lung
fibroblast (MRC-5) monolayers. Virus stocks were pre-
pared using infected cell culture supernatants 7–10 days
after infection and their titers were determined using a
rapid shell vial assay (Chou and Scott, 1988) with mono-
clonal antibody E13, which detects IE proteins of HCMV
(Argene-Biosoft, Varilhes, France).
For 35S-labeled viral stocks, MRC-5 cells were infected
ith AD 169 HCMV for 2 h at a multiplicity of infection
m.o.i.) of 0.1, rinsed, and refed with culture medium. After
days, medium was replaced with culture medium con-
aining 50 mCi [35S]Met–Cys per milliliter (NEN LIFE,
aris, France). Supernatant fluid was collected 4–6 days
ater and clarified by centrifugation. Virus was then con-
entrated by ultracentrifugation at 13,000 rpm for 1.5 h at
°C. The virus pellet was resuspended in culture me-
ium and stored in aliquots at 280°C.
ells
The human colon carcinoma cell line Caco-2 was
sed between passages 60 and 90. Cells were cultured
n Dulbecco’s modified Eagle’s minimum essential me-ium (DMEM), supplemented with 15% heat-inactivated
etal calf serum and 1% nonessential amino acids, in a
0% CO2 atmosphere at 37°C. Cells were seeded either
in 24-well tissue culture plates (TPP via Polylabo, Stras-
bourg, France) or on Transwell-clear filters (filter diame-
ter, 12 mm; pore size, 0.4 mm; Costar, Dominique
Dutcher, Brumath, France). For studies in 24-well tissue
culture plates, cells were seeded at 4 3 104 per milliliter
nd cultured on 14-mm-diameter glass coverslips. Me-
ium was changed daily. For studies on Transwell-clear
ilters, experiments were performed using cells (106/150
ml) seeded onto inverted filters, as previously described
(Esclatine et al., 2000). Apical and basal media of filters
were replaced at 2-day intervals and monolayers were
used 14 days after seeding.
Virus infection of Caco-2 cells
Undifferentiated (5 days post seeding) and fully differ-
entiated (14 days post seeding) cells were infected at
different m.o.i. Undifferentiated and differentiated cells
were characterized by expression of sucrase isomaltase,
as previous described (Jourdan et al., 1995). As shown by
Hudson (1988), infectivity of HCMV could be enhanced
by centrifugation during the inoculation period. Absorp-
tion was thus conducted by centrifugation at 4°C for 45
min at 1400 g for cells on coverslips, as described by
Zweygberg Wirgart et al. (1990), and at 350 g for cells on
filters. Fully differentiated, filter-grown cells were in-
fected with HCMV through the basolateral membrane.
Inoculum was then aspirated, and 1 ml fresh culture
medium was added. Cells were incubated at 37°C with
10% CO2 and, at various times after infection, removed
and processed for the different assays.
Antibodies
Murine MAb clone E13 directed against human HCMV
IE antigens was from Argene-Biosoft. The mouse anti-
heparan sulfate MAb was purchased from Seikagaku
(Coger, Paris, France). Rabbit polyclonal anti-annexin II
antibody was a gift from Franc¸oise Russo-Marie (INSERM
U332, Paris, France) (Trouve et al., 1999). The anti-p11
MAb was obtained from Transduction Laboratories (Bec-
ton–Dickinson, Le-Pont-de-Claix, France). Fluorescein
isothiocyanate (FITC)-conjugated and tetramethyl rhoda-
mine isothiocyanate (TRITC)-conjugated goat anti-mouse
immunoglobulin G (IgG) was purchased from Sigma
(Saint Quentin Fallavier, France). FITC-conjugated anti-
rabbit IgG was obtained from Jackson ImmunoResearch
Laboratories via Interchim (Montluc¸on, France).
Indirect immunofluorescent assay
Caco-2 cells cultured on glass coverslips or on Trans-
well filters were fixed in 4% paraformaldehyde for 15 min
at room temperature. After three washes in phosphate-
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31LOCALIZATION OF HS LIMITS HCMV ENTRY IN Caco-2 CELLSbuffered saline (PBS), cells were stained for annexin II,
p11, or HS by incubation with the antibodies described
above for 60 min at room temperature. After three
washes in PBS, incubation with an FITC-conjugated sec-
ond antibody was performed for 60 min at room temper-
ature. After three final washes in PBS, cells were
mounted on glass slides with Glycergel (Dako) and ex-
amined using a laser scanning confocal microscope
(Leica TCS). In some experiments, cells were permeabil-
ized using 0.2% Triton X-100 before reaction with the
primary antibody. Cells were counterstained with pro-
pidium iodide (Dakopatts).
Flow cytometric analysis
After removing cells with trypsin-EDTA, 1 ml DMEM
with 15% fetal calf serum was added and samples were
centrifuged 5 min at 600 g. The pellet was washed twice
with cold PBS and fixed in cold methanol for 20 min at
4°C. After fixation, cells were washed once with cold
PBS and resuspended in 0.5 ml PBS containing 0.2%
gelatin and an appropriate dilution of E13 MAb. After 1 h
incubation at room temperature, cells were washed
twice with cold PBS and then incubated for 1 h at room
temperature with fluorescein isothiocyanate-labeled
anti-mouse antibody. Cells were again washed twice,
resuspended in 0.5 ml of PBS, and stored in the dark at
4°C overnight.
Samples were analyzed on a FACSCalibur flow cytom-
eter equipped with a 488 nm argon laser (Becton–Dick-
inson) and 10,000 events were collected. Data analysis
was performed with Cell Quest software (Becton-Dickin-
son). The percentages of positive cells and the mean
fluorescence intensities were determined on fluores-
cence histograms, using a region defined according to
isotype control analysis. Data presented are representa-
tive of three separate experiments.
Inhibition assays of infectivity
Soluble GAGs. Caco-2 cells grown on 24-well tissue
culture plates were infected with HCMV at m.o.i. be-
tween 0.1 and 0.5. Heparin, from porcine intestinal mu-
cosa, and chondroitin sulfate, from bovine mucosa and
dextran sulfate (average molecular weight 5000), were
purchased from Sigma. These constituents were dis-
solved in PBS at concentrations indicated below and
added at the same time as the virus. Virus absorption
was performed as described above. After removal of
virus, monolayers were rinsed three times with PBS.
Cells were further incubated at 37°C for 48 h. Cultures
were then fixed in cold acetone (90% in distilled water) at
220°C for 20 min and immunostained for HCMV IE
proteins with MAb E13.
Enzymatic treatment of cells. Heparinase I (Sigma),
heparinase III (Seikagaku), or chondroitinase ABC
(Sigma) were reconstituted in PBS1 (Sigma) containing0.1% glucose, 1% fetal calf serum, and 0.1% bovine serum
albumin. Cell monolayers were pretreated before infec-
tion with the indicated concentrations of enzymes. En-
zyme incubations were performed at 37°C for 1 h. Mono-
layers were rinsed and virus absorption was assayed at
4°C as described above. Cells were fixed 48 h postin-
fection and immunostained for HCMV IE proteins with
MAb E13.
Specific antibodies. Caco-2 cells grown in 24-well tis-
sue culture plates were infected with HCMV in the ab-
sence or presence of antibodies. Rabbit polyclonal anti-
annexin II antibody or normal rabbit serum were added
to cells for 1 h at 37°C at various concentrations. Cells
were then infected with HCMV at an m.o.i. 0.1 in the
presence of the antibody. Cells were fixed 24 h postin-
fection and then immunostained for HCMV IE proteins
with MAb E13.
Virus attachment and neutralization assays
35S-labeled virus, treated with various agents (heparin,
hondroitin sulfate, and dextran sulfate) or left untreated,
as added to confluent Caco-2 cells grown in 24-well
issue culture plates. Alternatively, Caco-2 cells, which
ad been incubated with the different enzymes as de-
cribed above, were infected with 35S-labeled virus. Virus
was incubated with the cells for 45 min at 4°C. After
incubation, free virus was removed and cell monolayers
were washed three times with cold PBS. Cells were then
lysed by adding 200 ml 1 N NaOH at room temperature.
After neutralization with HCl, lysed cells were counted in
a scintillation counter (Packard). The percentage of re-
covered virus bound to cells was then determined.
Protein electrophoresis
Cells grown on 25-cm2 tissue culture flasks were
ashed in cold HBS (50 mM HEPES, 200 mM NaCl, pH
.5). Cells were lysed directly in cold lysis buffer contain-
ng protease inhibitors (50 mM HEPES, 40 mM NaCl,
riton X-100, 5 mg/ml pepstatin A, 10 mM E64, 1 mM
PMSF, 5 mg/ml DOC) at 4°C and subjected to low-speed
centrifugation for 30 min at 15,000 rpm to remove cellular
debris. In some experiments, cells were scraped with a
rubber policeman, suspended in distilled water, and ho-
mogenized at 4°C. The homogenates were centrifuged
at 100,000 g for 1.5 h at 4°C to separate soluble and
membrane fractions (Blais et al., 1987). Cell lysates were
separated by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) and transferred to a nitrocellulose mem-
brane (Amersham, Saclay, France) as previously de-
scribed (Sapin et al., 1997).
Immunoblotting
Expression of annexin II and annexin II light chain was
assessed using the Western blot technique. Membranes
were incubated with specific antiserum (1:2000 for an-
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32 ESCLATINE ET AL.nexin II and 1:5000 for annexin II light chain) in blocking
buffer for 2 h at room temperature. Membranes were
washed and subsequently incubated in blocking buffer
containing a dilution of an alkaline phosphatase conju-
gated anti-rabbit (1:4000) or anti-mouse (1:2000) IgG an-
tibody (Sigma) for 2 h at room temperature. Membranes
were washed and then incubated in 5-bromo-4-chloro-3-
indolylphosphate nitroblue tetrazolium (Sigma) at room
temperature.
Virus overlay
Protein blots were treated with blocking solution (PBS
containing 5% bovine serum albumin) at 4°C overnight.
Blots were washed three times and incubated with
[35S]HCMV (3 3 107 cpm in 5 ml of PBS) at 4°C for 8 h.
hey were washed three times with PBS and air-dried.
irus binding was detected by autoradiography using
odak hyperfilm.
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